News summary

Consumer CGM flagged insulin resistance that normal HbA1c missed, preprint finds

Source: Longevity Docs News • Published: 11 Nov 2026, 00:00

Summarized by Masters of Longevity from Longevity Docs News.

A preprint found week‑long average CGM tracked fasting insulin better than HbA1c.

Consumer CGM flagged insulin resistance that normal HbA1c missed, preprint finds
Key Takeaways
  • Week‑long CGM average was linked to one‑eighth insulin variance.
  • The study analyzed 7,930 self‑selected consumer CGM users without diabetes.
  • Authors reported consults and equity ties with Levels Health.
Read the full article at Longevity Docs News ↗

Continue exploring

Recommended MoL Picks

MoL PickFrom Metrics to Better LivingEverstride’s May 2026 Consumer Health Market Briefing shows a wellness market moving from products to systems, from tracking to guidance, and from optimization to meaning. The next winners in longevity may not be the companies that measure the most. They may be the ones that help consumers translate health data into a life they actually want to live.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.